Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ralph Keller"'
Autor:
Ralph Keller, Josef‐A. Patron
Publikováno v:
geotechnik. 42:98-110
Autor:
Peter C. Thuss-Patience, Ralf-Dieter Hofheinz, Salah-Eddin Al-Batran, S. Hegewisch-Becker, Nils Homann, Ralph Keller, Martin Fuchs, Andrea Tannapfel, Ullrich Graeven, Volker Kunzmann, Nadine Schulte, Michael Pohl, Kirsten Merx, Swantje Held
Publikováno v:
International journal of cancerREFERENCES. 149(6)
Perioperative chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) is a mainstay in the treatment of esophagogastric adenocarcinomas (EGA). Trastuzumab improved survival when added to chemotherapy in patients with HER-2-posi
Autor:
Helmut Friess, Dirk Waldschmidt, Holger Schulz, Martin Fuchs, Eray Goekkurt, Thomas Geer, Volker Heinemann, Wolfgang Blau, Marcel Reiser, Metin Senkal, Uwe Pelzer, Ralf Jakobs, Michael Stahl, Matthias Egger, Swantje Held, Jens T. Siveke, Ralph Keller, Christina Große-Thie, Thomas J. Ettrich, Stefan Boeck, Hubert J. Stein, Ingo Hartlapp, Georg Maschmeyer, Peter Fix, Thomas Südhoff, U. Lindig, Elke Hennes, Marcus Bahra, Volker Kunzmann, Ingo Klein, Frank Kullmann, Gabriele Margareta Siegler, Christoph Kahl, Hana Algül, Christoph-Thomas Germer, Uwe M. Martens, Stefan Mahlmann
Summary Background The optimal preoperative treatment for locally advanced pancreatic cancer is unknown. We aimed to compare the efficacy and safety of nab-paclitaxel plus gemcitabine with nab-paclitaxel plus gemcitabine followed by fluorouracil, leu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1066cfe3208263c113f5fd0c464ccbd8
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85099144148
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85099144148
Autor:
D. Valta-Seufzer, Friedrich Anger, Martin Fuchs, I. Hartlapp, Stefan Boeck, Uwe Pelzer, Gabriele Margareta Siegler, Dirk Waldschmidt, H.A. Stang, Eray Goekkurt, Swantje Held, Volker Kunzmann, Jens T. Siveke, C-T. Germer, Frank Kullmann, Hana Algül, Thomas J. Ettrich, Ralph Keller, Uwe M. Martens, Volker Heinemann
Publikováno v:
Annals of Oncology. 32:S1091
Autor:
Hana Alguel, Elke Hennes, Volker Kunzmann, Eray Goekkurt, Ralf Jakobs, Markus Kapp, Gabriele Margareta Siegler, Uwe Pelzer, Frank Kullmann, Ralph Keller, Uwe M. Martens, Dirk Waldschmidt, Jens T. Siveke, Stefan Boeck, Christoph-Thomas Germer, Peter Ferenczy
348 Background: Although there is a strong rationale for downstaging non-resectable pancreatic ductal adenocarcinoma (PDAC) for secondary resections by multi-agent chemotherapy, evidence from prospective randomized studies is missing. Methods: This p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a985c17b71c6b887f260d57eb51fa103
Autor:
Richard Greil, Kersten Borchert, Lothar Mueller, E. Van Cutsem, Johannes Meiler, Markus Moehler, Baruch Brenner, Ralph Keller, F. Longo Muñoz, Thomas J. Ettrich, Peter C. Thuss-Patience, A. Karatas, J. Hecker, M. Alsina, R.D. Hofheinz, Julian Larcher-Senn, S.-E. Al-Batran, Manfred P. Lutz, Arndt Vogel, Sylvie Lorenzen, Annett Maderer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cc0e0e7fb33ad84e9c786430d954684
https://www.ncbi.nlm.nih.gov/pubmed/32176989
https://www.ncbi.nlm.nih.gov/pubmed/32176989
Autor:
Eray Goekkurt, Uwe M. Martens, P. Ferenczy, Stefan Boeck, Volker Heinemann, Gabriele Margareta Siegler, I. Klein, Hana Algül, Frank Kullmann, Dirk Waldschmidt, E. Hennes, Jens T. Siveke, I. Hartlapp, Ralph Keller, Thomas J. Ettrich, C.-T. Germer, Uwe Pelzer, Martin Fuchs, Hubert J. Stein, Volker Kunzmann
Publikováno v:
Annals of Oncology. 30:v253
Background The optimal preoperative treatment for LAPC is unknown. This first prospective, randomised trial was designed to compare the efficacy and safety of nab-Paclitaxel and Gemcitabine (nPG) with Fluorouracil, Leucovorin, Irinotecan, Oxaliplatin
Autor:
Baruch Brenner, Kersten Borchert, Ralph Keller, Lothar Mueller, Julian Larcher-Senn, Thomas J. Ettrich, Maria Alsina, Federico Longo, Arndt Vogel, Eric Van Cutsem, Peter C. Thuss-Patience, Manfred P. Lutz, Markus Moehler, Sylvie Lorenzen, Ralf Hofheinz, Salah-Eddin Al-Batran, A. Karatas, Johannes Meiler, Richard Greil
Publikováno v:
Journal of Clinical Oncology. 35:4011-4011
4011 Background: Most ESCC pts have advanced disease at time of diagnosis. Chemotherapy (CTX) is used to improve quality of life (QoL) and overall survival (OS), but still with limited impact. Prior studies suggested increased efficacy of EGFR antibo
Publikováno v:
Diseases of the Colon & Rectum. 39:969-976
PURPOSE: This study was undertaken for the comparison of local resection for early rectal carcinomas using transanal endoscopic microsurgery or anterior resection. METHODS: Data from 50 of 52 patients with proven adenocarcinoma (GI/II) and intralumin
Diss. no. 15372 techn. sc. SFIT Zurich.
Im Buchh.: Aachen : Shaker. Literaturverz.
Im Buchh.: Aachen : Shaker. Literaturverz.
Externí odkaz:
http://e-collection.ethbib.ethz.ch/show?type=diss&nr=15372